Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

XRISE-M: X-radiography facility for solidification and diffusion studies of alloys aboard sounding rockets.

The Review of scientific instruments·2020
Same author

ARTEC-A furnace module for directional solidification and quenching experiments in microgravity.

The Review of scientific instruments·2020
Same author

Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.

Canadian respiratory journal·2012
Same author

Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2011
Same author

Limestone concretions at the ends of the fingers.

Annales de dermatologie et de syphiligraphie·2010
Same author

Management of chronic bronchitis and acute exacerbations of chronic bronchitis.

International journal of antimicrobial agents·2008

Video Experimental Relacionado

Updated: Jul 20, 2026

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
13:48

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

Published on: June 24, 2012

El paludismo. la malaria. ¿Puede la OMS hacer retroceder la malaria?

M Balter

    Science (New York, N.Y.)
    |February 24, 2001
    PubMed
    Resumen

    La Organización Mundial de la Salud lanzó Roll Back Malaria en 1998 para reducir a la mitad las muertes por malaria en una década. Los expertos creen que este ambicioso objetivo es alcanzable, aunque algunos cuestionan su viabilidad.

    Área de la Ciencia:

    • Iniciativas globales de salud para la salud.
    • Control de las enfermedades infecciosas.
    • Política de salud pública política de salud pública.

    Sus antecedentes:

    • La Organización Mundial de la Salud (OMS) inició la campaña para hacer retroceder la malaria en octubre de 1998.
    • El objetivo principal era reducir la mortalidad mundial por malaria en un 50% en diez años.

    Más Videos Relacionados

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
    08:11

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

    Published on: November 14, 2016

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
    03:07

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

    Published on: July 12, 2024

    Videos de Experimentos Relacionados

    Last Updated: Jul 20, 2026

    Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
    13:48

    Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

    Published on: June 24, 2012

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
    08:11

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

    Published on: November 14, 2016

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
    03:07

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

    Published on: July 12, 2024